Matches in Nanopublications for { ?s ?p "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1239817.RAk-W3vo4DrwuT6XPa4v2YbxhIYK6T7xwCciLqym1ibwQ130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239817.RAk-W3vo4DrwuT6XPa4v2YbxhIYK6T7xwCciLqym1ibwQ130_provenance.
- NP1239821.RAj8TxclIwo8erF5Dv9HY7gwUi8qqzgKbNrf9ETni2kqg130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239821.RAj8TxclIwo8erF5Dv9HY7gwUi8qqzgKbNrf9ETni2kqg130_provenance.
- NP1239824.RAkFuOARMuosimiSfZeyS8rWMz8c6Txkq7lUzPXaiIezc130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239824.RAkFuOARMuosimiSfZeyS8rWMz8c6Txkq7lUzPXaiIezc130_provenance.
- NP1239828.RAhCl-rgoBKlDNhZ-9f0uTtchJ6diA8dTWXw83tU0p5eE130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239828.RAhCl-rgoBKlDNhZ-9f0uTtchJ6diA8dTWXw83tU0p5eE130_provenance.
- NP1239815.RAP-ZmRMtrXUu0Ob5S308Oh1D1O7TJvTFBmg_M9j7ttPk130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239815.RAP-ZmRMtrXUu0Ob5S308Oh1D1O7TJvTFBmg_M9j7ttPk130_provenance.
- NP1239820.RAyT747uSlZFyy67GoxNs7M6mA43rvWJDuZwvvtrRVzZE130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239820.RAyT747uSlZFyy67GoxNs7M6mA43rvWJDuZwvvtrRVzZE130_provenance.
- NP1239822.RA4rMvkfrnE40mBplWe5AoSr98a_JUufEUH5hQxb7aDjs130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239822.RA4rMvkfrnE40mBplWe5AoSr98a_JUufEUH5hQxb7aDjs130_provenance.
- NP1239825.RA7hvVX0Xr_6FcMLsaa8Vgc3SdJz_CNrJ-WNSESSB5Sl8130_assertion description "[Phosphatidylinositol-3-kinase (PI3K)/AKT pathway mutations are associated with cancer and phosphatidylinositol-4, 5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA) gene mutations have been observed in 25-45% of breast cancer samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1239825.RA7hvVX0Xr_6FcMLsaa8Vgc3SdJz_CNrJ-WNSESSB5Sl8130_provenance.